Loading

PeerCurrent.com|Stay current with the people and research shaping what comes next.

About Privacy Terms Support

PeerCurrent

PcPeerCurrent

Your Feed AI Summary Saved Board Expert Discussion This Week in Your Field

Follows Journals Trials Guidelines Markets

Set your cadence Alerts Settings Help

Back to follows

Clinical trial

NCT07382726

1 development in the corpus

NCT07382726

Following this puts new work involving it at the top of your briefing, with a note saying why it is there. Links are taken from the source record, never inferred.

For You Latest Breakthroughs Trials1 Reviews Guidelines

Latest

Everything in the corpus, newest first.

AUG 11, 2026 · PHASE 1 TRIAL

Phase 1 Study Of Izalontamab Brengitecan + Adagrasib In NSCLC - The IZA-A Trial

ClinicalTrials.gov

Phase 1 study of a novel drug combination in advanced NSCLC; registry record with no results posted; designed to evaluate safety in a small population.

PreliminaryIza-bren NCT07382726 Adagrasib

Reported

Planned enrollment18

PhasePhase 1

Primary outcome measureSafety and Adverse Events through study com…

PeerCurrent.com|Stay current with the people and research shaping what comes next.

About Privacy Terms Support